Cargando…
The NIMH-MATRICS project for developing cognition-enhancing agents for schizophrenia
The US National Institute of Mental Health supported an initiative to facilitate the development of pharmacological agents for enhancing neurocognition in patients with schizophrenia. This has been accomplished through a consensus-building process that has included representatives from academia, the...
Autor principal: | Marder, Stephen R. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Les Laboratoires Servier
2006
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3181758/ https://www.ncbi.nlm.nih.gov/pubmed/16640121 |
Ejemplares similares
-
The Open Translational Science in Schizophrenia (OPTICS) project: an open-science project bringing together Janssen clinical trial and NIMH data
por: Wilcox, Marsha A., et al.
Publicado: (2018) -
Meta-Analysis of Repository Data: Impact of Data Regularization on NIMH Schizophrenia Linkage Results
por: Walters, Kimberly A., et al.
Publicado: (2014) -
Saving time and money: a validation of the self ratings on the prospective NIMH life-chart method (NIMH-LCM)
por: Born, Christoph, et al.
Publicado: (2014) -
NIMH funding opportunities for NeuroAIDS therapeutics development research
por: Bao, Jing, et al.
Publicado: (2006) -
Enhancing adherence to mood charting with an online version of the NIMH Life Chart
por: Lieberman, Daniel
Publicado: (2010)